KRELYSIS

Pharmaceutical preparations, namely, preparations for the treatment and prevention of brain and central nervous system diseases and disorders; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, stroke, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents